Salt Lake Life Science Angels Invests in Larada Sciences

Salt Lake City, UT - May 21, 2007 - Salt Lake Life Science Angels (SLLSA) announced today that it has made an investment in Larada Sciences, Inc., an early-stage company developing a technology for the safe and effective non-chemical treatment of head lice.

In 2006, SLLSA invested in:

• Q Therapeutics, Inc., a company developing cell-based therapies to treat multiple sclerosis, spinal cord injury, enzyme deficiency diseases, and other demyelinating diseases of the central nervous system; and
• SentrX Animal Care, Inc, a leading provider of innovative healing biomaterials for horses and small animals.

About SLLSA:
SLLSA is a Salt Lake City-based angel investment group that was founded in 2006 by Ted Stanley, Larry Rigby, and Andrew Laver to facilitate investment in seed-stage life science companies in Utah and the surrounding region. SLLSA is made up of accredited executives, entrepreneurs, scientists, and clinicians seeking investment opportunities in early-stage companies.

Sponsors of SLLSA include: the Parr Waddoups Brown Gee & Loveless Business Transactions Group, the Stoel Rives Technology & Intellectual Property Practice Group, Wasatch Venture Fund, and the Utah Fund of Funds.

For additional information regarding SLLSA, please visit www.SLLSA.com.

About Larada Sciences:
Larada Sciences, Inc. was formed to develop, manufacture, and market proprietary medical products and services based on breakthrough technology for the safe and effective non-chemical treatment of head lice. The company was founded in 2006 by University of Utah Professor Dale Clayton and by seasoned entrepreneurs.

For more information about Larada Sciences, please visit www.laradasciences.com

Contacts:
Andrew Laver
Salt Lake Life Science Angels
801-308-1001

Randall Block
Larada Sciences, Inc.
801-533-5423

###